Barclays downgraded Moderna (NASDAQ: MRNA) to Equal Weight from Overweight in a note Tuesday, citing policy risks, a lack of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback